1. Home
  2. LRE vs GDTC Comparison

LRE vs GDTC Comparison

Compare LRE & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRE
  • GDTC
  • Stock Information
  • Founded
  • LRE 2001
  • GDTC 2018
  • Country
  • LRE Japan
  • GDTC Singapore
  • Employees
  • LRE N/A
  • GDTC N/A
  • Industry
  • LRE
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • LRE
  • GDTC Health Care
  • Exchange
  • LRE Nasdaq
  • GDTC Nasdaq
  • Market Cap
  • LRE 24.0M
  • GDTC 21.5M
  • IPO Year
  • LRE 2023
  • GDTC 2023
  • Fundamental
  • Price
  • LRE $1.60
  • GDTC $1.85
  • Analyst Decision
  • LRE
  • GDTC Buy
  • Analyst Count
  • LRE 0
  • GDTC 1
  • Target Price
  • LRE N/A
  • GDTC $5.00
  • AVG Volume (30 Days)
  • LRE 70.5K
  • GDTC 8.7K
  • Earning Date
  • LRE 01-01-0001
  • GDTC 01-01-0001
  • Dividend Yield
  • LRE N/A
  • GDTC N/A
  • EPS Growth
  • LRE N/A
  • GDTC N/A
  • EPS
  • LRE N/A
  • GDTC N/A
  • Revenue
  • LRE $110,330,328.00
  • GDTC $368,838.00
  • Revenue This Year
  • LRE N/A
  • GDTC $5.37
  • Revenue Next Year
  • LRE N/A
  • GDTC N/A
  • P/E Ratio
  • LRE N/A
  • GDTC N/A
  • Revenue Growth
  • LRE 3.92
  • GDTC N/A
  • 52 Week Low
  • LRE $1.10
  • GDTC $1.20
  • 52 Week High
  • LRE $2.49
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • LRE 49.41
  • GDTC 47.67
  • Support Level
  • LRE $1.44
  • GDTC $1.65
  • Resistance Level
  • LRE $1.57
  • GDTC $1.88
  • Average True Range (ATR)
  • LRE 0.15
  • GDTC 0.05
  • MACD
  • LRE -0.00
  • GDTC 0.01
  • Stochastic Oscillator
  • LRE 34.21
  • GDTC 87.28

About LRE Lead Real Estate Co. Ltd

Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: